ISO 20916 provides appropriate IVD medical device definitions and insights on the roles and responsibilities of all involved parties and differentiates interventional CP studies.
Emergo by UL's Human Factors Research & Design (HFR&D) experts examine how Europe's MDR affects HFE and usability requirements for medical device manufacturers.
The European Commission has published a guide featuring complete timetables that incorporate recent regulatory postponements.
Chinese regulators have updated marketing application requirements for makers of combination products featuring pharmaceutical and medical device components. Learn more about NMPA regulations for combination products, medical devices and IVDs.
New legislation is being rolled out in stages to match changing European regulations and prepare the ground for a mutual recognition agreement.
The European Commission has published a new factsheet explaining how the upcoming Medical Devices Regulation (EU) 2017/745 (MDR) will affect manufacturers of low-risk Class I medical devices.
The new regulation retains most of the provisions of the interim regulation and serves as the fundamental basis of the SFDA’s authority to regulate medical devices.
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has posted new guidance regarding medical devices placed on the market in Great Britain
Chinese regulators plan new unit for clinical evaluation efforts, as well as revise animal testing study guidelines for medical device registrants. Learn more at Emergo by UL.
The Ministry of Food and Drug Safety (MFDS), South Korea’s medical device market regulator, plans to roll out several amendments to the country’s Medical Devices Act over the course of 2022, and has also expanded its list of devices eligible for electronic